Clinical Studies
Comparing the Ankle brachial Index measured by TM-ABI and by the conventional Doppler probe method, the clinical study returned a coefficient of correlation r= 0.88 (95% CI: from 0.76 to 0.97)
Technical Specifications
The TM-ABI is the first valuable automated ankle-brachial index measuring device based on oscillometric and volume plethysmography at brachial and ankles
ABI-Stats
15 -20% of people over 60 years old have PAD

TM-ABI System: Peripheral Artery Disease (PAD) Assessment 

tmabideviceWe offer the first valuable automated ankle-brachial index (ABI) measuring device , based on  volume plethysmography analysis.
The blood pressure on the upper and lower extremities is measured simultaneously, resulting in the calculation of the ankle-brachial index (ABI). The result of the examination is clear and straight forward. Only what is really important – the left ABI and right ABI  – are displayed. The measurement is repeatable and can be performed in only three minutes, instead of the usual 30 minutes that are required by the Doppler ultrasound method.  The TM-ABI measures ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries.
By adding an oximeter on the toe (TM-ABI Plus system), the Toe-Brachial Index (TBI) is also calculated.
The TM-ABI system is indicated for use on adult subjects at risk of having or developing peripheral arterial disease (PAD).TM-ABI system is intended for the rapid measurement of ankle-brachial pressure index (ABPI), or ankle-brachial index (ABI), and pulse volume recording (PVR) / volume plethysmography in adults. It is suitable for use in wound care assessment, for assessing symptomatic PAD, and as a screening device for PAD. 

TM-FLOW System :
Combining technologies :TM-ABI , SweatC and LD-Oxy

tmflownewTM-FLOW System combines TM-ABI, LD-Oxy (an oximeter for detecting precise RR intervals and skin microcirculation disorders ) and SweatC (a Galvanic Skin response related to the function of the sweat glands.). TM-Flow system performs the assessment of vascular function and autonomic nervous system in one exam.
It responds to the needs of the physician and represents a dramatic improvement of the early detection of the complications of chronic disease such as diabetes. 
It gives timely information and allows to the physician more treatment options.
Not infrequently, the physicians face patients who have chronic metabolic disease or other comorbid conditions and pain symptoms in the legs. At times, differentiating vascular pain from neuropathic pain can be difficult. The symptoms of small fiber neuropathy and peripheral artery disease can overlap and mimic each other. Symptoms can include tingling, pain, burning, numbness, shooting sensations, cramping, or a sensation of “thick skin” or that the part is “asleep”. The symptoms may vary with positioning and activity level. Although the conditions may imitate each other, the causes are often unrelated. It is imperative to distinguish between small fiber neuropathy and peripheral artery disease because the treatments are quite different.

 

 

  • Medical Screening is an authorized distributor of LD Technology (Manufacturer of medical devices).